Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making-Reference-Cited by-同舟云学术

Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making

Published:2017-09 Issue:9 Volume:26 Page:1033-1039
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Berger Marc L.¹,Sox Harold²,Willke Richard J.³,Brixner Diana L.⁴,Eichler Hans-Georg⁵,Goettsch Wim⁶,Madigan David⁷,Makady Amr⁶,Schneeweiss Sebastian⁸,Tarricone Rosanna⁹,Wang Shirley V.⁸,Watkins John¹⁰,Daniel Mullins C.¹¹

Affiliation:

1. New York City NY USA

2. Patient-Centered Outcomes Research Institute; Washington DC USA

3. International Society for Pharmacoeconomics and Outcomes Research; Lawrenceville NJ USA

4. University of Utah; Salt Lake City UT USA

5. European Medicines Agency; London UK

6. Zorginstituut Nederland and University of Utrecht; Utrecht The Netherlands

7. Columbia University; New York City NY USA

8. Brigham and Women's Hospital; Harvard Medical School; Boston MA USA

9. Bocconi University; Milan Italy

10. Premera Blue Cross; Mountlake Terrace WA USA

11. University of Maryland; Baltimore MD USA